Batm Advanced Communicat... Share Discussion Threads

[fse] 15/9/2022 18:41

ADOR and Adaltis work hand in hand if you knew that you would not spout so much nonsense. As I have said you comment on matters you dont understand and then you start drawing wrong conclusions.
Why dont you call BATM CFO and ask all your questions or maybe call Shore Capital I am sure they would be glad to answer the questions from such an important investor such as you tell us all you are.

You seem intent on discrediting the company from any angle you can dig up. Its the oldest ruse around ... profess an interest then introduce a measure of doubt.

[kooba] 15/9/2022 18:31

Quick refresh..not many companies do not have a ceo.What is the difference between a CEO and COO? A CEO is the top-most ranking person at a firm that is responsible for the long-term health and direction of the firm while a COO is the second-highest individual in the firm that reports to the CEO and is responsible for the day-to-day operations of the firm.

[kooba] 15/9/2022 18:28

What is false exactly ??Adaltis has no ceo the chap appointed has left stage left , when I don't know.Never said they didn't have a coo... but that is not a ceo , they are different roles.Ador is a separate company with separate ownership structure to Adaltis so irrelevant to my point.Batm opens 95% of Adaltis and 38% of ADOR..they are not the same company at all.

[fse] 15/9/2022 18:14

Kooba stop posting false or misleading information.
Adaltis has a COO
Just posting this before you claim ADOR does not have someone at the top.


Appointment of CEO of ADOR Diagnostics
LEI: 213800FLQUB9J289RU66
19 July 2022

BATM Advanced Communications Limited
(“BATM” or “the Group”)

Appointment of CEO of ADOR Diagnostics

Bioscience expert appointed to lead advanced molecular diagnostics associate company

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce the appointment of Dr. Eran Zahavy as CEO of ADOR Diagnostics (“ADOR”), the Group’s associate company that is developing the NATlab rapid molecular diagnostics platform.

Dr. Eran Zahavy has more than 20 years’ experience in leading positions in government and private bio-science organisations. This includes roles such as R&D manager for biological pathogens diagnostics and Head of Innovation at the Israel Institute for Biological Research (“IIBR”). During the pandemic, at IIBR he oversaw the development of the BriLife COVID-19 vaccine in collaboration with US-based NRx Pharmaceuticals. Other roles have included serving as CTO at Hutchison Kinrot, the operator of a technology incubator in Israel and a seed investor in water and cleantech-related technologies; CTO of TACount, a developer of imaging-based microbiological testing technology; and as scientific advisor to Longliv Ventures, a strategic investor in health-tech start-ups and part of the CK Hutchison Holdings Group.

For the last few years, Dr. Zahavy has served as CTO of the Group’s Bio-Medical Division and as Senior Scientific Consultant to ADOR and BATM’s Adaltis diagnostics subsidiary. During this time, he has been instrumental in the progress made in the Group’s molecular diagnostics activities.

Dr. Zahavy holds a PhD in Chemistry & Biophysics from the Hebrew University and undertook a postdoc at the University of Texas, Austin and the University of California, San Diego. He has more than 40 peer reviewed scientific publications to his name as well as patents.

Dr. Zvi Marom, CEO of BATM, said: “We’re pleased to have appointed Eran as CEO of ADOR. He has an impressive track record of bioscience development and has been critical to the fantastic progress that we have made in our Bio-Medical Division in recent years. It is an exciting time for ADOR as we move to the pre-production phase and towards becoming a commercial clinical solution. We look forward to leveraging Eran’s experience and expertise for the next stage of development in ADOR.”

ADOR is developing the NATlab system, which is a molecular diagnostics platform that uses the isothermal amplification (RCA) process to provide rapid sample-to-answer testing of pathogens. The NATlab instrument tests for multiple pathogens using a single cartridge, with different cartridges being designed for different infectious disease panels, such as meningitis, respiratory diseases, STIs and more. The Group, through ADOR and Adaltis, is also partnering with the Stop TB Partnership to develop a solution for the rapid and comprehensive diagnosis of tuberculosis.

Dr. Eran Zahavy, CEO of ADOR Diagnostics, added: “I am excited to be taking up this role with ADOR. We are paving a new path for the diagnosis of infectious diseases. With a rapid diagnostics solution that can be operational at both the point of care and in labs, we can enable the appropriate and immediate treatment of disease, which is better for patients and for public health authorities.”

[kooba] 15/9/2022 17:58

Wonder why the Chinese never exercised the option?https://www.investegate.co.uk/batm-advanced-comm--bvc-/rns/batm-s-adaltis-receives-chinese-investment/201612210700054174S/Egens also has an option to purchase a further 10% of Adaltis' share capital, which will be exercisable for 90 days after the approval of either Adaltis' 2016 or 2017 financial statements.

[kooba] 15/9/2022 17:54

FSE if I bore you just pop me on ignore and don't direct stupid gotcha posts to me there's a good fellow. It's not difficult. If you challenge me you are open to comment back...if that makes you look ill informed then that's the game you play.

[fse] 15/9/2022 17:52

This is interesting

Its an earlier MolGen instant covid test kit with very accurate results. Adaltis use this same technology to advance the diagnostics offerings.

[kooba] 15/9/2022 17:51

Who is the CEO of Adaltis ..I noticed this rns from a few years ago..looks good appointment.https://www.batm.com/rns-rnr/posts/2017/july/batm-appoints-senior-management-at-adaltis-as-it-widens-scope-of-its-molecular-biology-platform/It doesn't actually now appear to have a ceo and this chap is elsewhere..never mentioned his departure so can't work out if or how long he was in position.

[fse] 15/9/2022 17:42

Kooba....not interested zzzzzzzzzzzz

[kooba] 15/9/2022 17:42

Just to remind on the tone of your post to me. Correct response is an apology when you make such an ignorant post."Err Kooba you missed something like how did BATM manage to pay for Telco Systems because they own it outright.As Simon Thompson referenced the company has no debt with @30% of company assets in cash.How in the world did such an unsuccessful company find itself in this position.And you want people to take you seriously"

[fse] 15/9/2022 17:40

From twitter but an interesting reminder that BATM/Adaltis are actually running a profitable and growing diagnostics platform.
As commented earlier the shortage of medical professionals boosts the significance of accurate testing and solutions that can save an enormous amount of time and money and prevent patients returning again and again.


"Standardised and easy approach to PCR Diagnostics
The Diagnostic Assay kits of EXTRAlab series were developed for detection of infection agents by real time PCR.
The proprietary development allows us to turn the procedure of real time PCR analysis from a complicated process, requiring
extensive specialized knowledge and practical experience, into a standardized, simple and readily reproducible procedure.
We provide convenient solutions in reagent configuration such as lyophilized, ready-to-use mixtures with a long shelf-life and the possibility to ship the kits at room temperature. All reagent kits can be used basically with all current real time PCR detection systems. The MOLgen line kits are CE marked."

[kooba] 15/9/2022 17:39

I think you do ..if you accuse me of not knowing how they funded Telco and you clearly didn't know yourself I was filling a large gap in your knowledge. If you want to challenge my posts directly expect a response sunshine. But advise do some homework first.

[fse] 15/9/2022 17:33

Kooba I did not ask for, and don't want or need your help or advice, so please stop offering.
Please and X

[oakville] 15/9/2022 08:08

Changed my next buy to average down from 24p to 21p

[kooba] 15/9/2022 06:45

Wow..and you want to be taken seriously....seriously?? Hope you absorbed the how did they fund telco question i answered, anything else i can clear up for you let me know. The information is out there is you bother to look before you throw out gotchas...that make you look silly.

[fse] 14/9/2022 23:20

Pockstoned. Put yourself on the list to be flushed 🚽
Please and X

[pockstones] 14/9/2022 23:13

Well Echoridge that’s a 109 posts since July 31st on Batm and you have not addressed corporate governance for this company that’s a lot of flushes keep pulling the chain

[echoridge] 14/9/2022 22:47

But FSE, he bade us farewell (so classy) and signed off with an 'x' and everything. that makes it all ok

[echoridge] 14/9/2022 20:54

Sorry, before you go back to your busy life, I must have missed your, like, point.

[echoridge] 14/9/2022 20:33

I'm not sure it would even be possible to have worse things to do.

[shiftytherat] 14/9/2022 20:11

So, now that we're all clear, the Milan Chamber of Commerce considers these documents to be non-public, as does the Italian registry, I will bid thee farewell. I have no financial interest in this company and have other things to do.

Good luck with your terrible investments in (or in some cases, jobs at) BATM.

Shifty x

[echoridge] 14/9/2022 19:41

so does the Milan Chamber of Commerce

[tradeterminator01] 14/9/2022 19:03

Rat - I agree with Resistance, sharing these screen grabs with the Milan Chamber of commerce, will most certainly be 'helpful' i look forward to seeing them!